Your browser is no longer supported. Please, upgrade your browser.
AMGN [NASD]
Amgen Inc.
IndexDJIA S&P500 P/E20.72 EPS (ttm)12.31 Insider Own0.20% Shs Outstand580.00M Perf Week3.34%
Market Cap145.68B Forward P/E14.00 EPS next Y18.22 Insider Trans-1.35% Shs Float576.47M Perf Month6.16%
Income7.26B PEG3.02 EPS next Q4.06 Inst Own77.70% Short Float1.98% Perf Quarter7.31%
Sales25.42B P/S5.73 EPS this Y-4.40% Inst Trans-1.55% Short Ratio4.28 Perf Half Y6.60%
Book/sh16.22 P/B15.73 EPS next Y8.23% ROA11.40% Target Price255.77 Perf Year15.03%
Cash/sh18.65 P/C13.68 EPS next 5Y6.86% ROE71.70% 52W Range210.28 - 276.69 Perf YTD10.96%
Dividend7.04 P/FCF23.75 EPS past 5Y6.30% ROI19.50% 52W High-7.33% Beta0.73
Dividend %2.76% Quick Ratio1.50 Sales past 5Y3.30% Gross Margin75.80% 52W Low21.94% ATR4.46
Employees24300 Current Ratio1.80 Sales Q/Q7.10% Oper. Margin35.90% RSI (14)67.87 Volatility1.43% 1.83%
OptionableYes Debt/Eq3.51 EPS Q/Q-3.10% Profit Margin28.60% Rel Volume0.65 Prev Close255.13
ShortableYes LT Debt/Eq3.50 EarningsApr 27 AMC Payout51.60% Avg Volume2.66M Price256.41
Recom2.30 SMA202.95% SMA507.28% SMA2007.06% Volume964,608 Change0.50%
Dec-29-20Initiated Daiwa Securities Buy $300
Oct-28-20Initiated UBS Neutral $232
Oct-26-20Upgrade Raymond James Mkt Perform → Outperform $255
Oct-12-20Upgrade Truist Hold → Buy
Oct-09-20Downgrade Truist Buy → Hold $251
Oct-09-20Downgrade Bernstein Outperform → Mkt Perform
Oct-08-20Downgrade Raymond James Outperform → Mkt Perform
Apr-15-20Resumed Guggenheim Neutral
Mar-31-20Initiated Wolfe Research Peer Perform
Mar-30-20Upgrade Raymond James Mkt Perform → Outperform $255
Mar-05-20Upgrade BofA/Merrill Neutral → Buy $245 → $250
Feb-27-20Initiated Barclays Equal Weight $235
Jan-31-20Downgrade Robert W. Baird Neutral → Underperform $173 → $185
Jan-21-20Upgrade Evercore ISI In-line → Outperform
Dec-24-19Initiated Raymond James Mkt Perform
Dec-17-19Resumed Morgan Stanley Overweight $280
Nov-12-19Initiated SunTrust Buy $256
Nov-05-19Upgrade Cantor Fitzgerald Neutral → Overweight $230 → $255
Oct-17-19Resumed BofA/Merrill Neutral $215
Aug-19-19Downgrade Mizuho Buy → Neutral $208 → $212
Apr-16-21 08:25AM  
Apr-14-21 01:47PM  
10:45AM  
Apr-08-21 10:32AM  
Mar-31-21 01:38PM  
07:29AM  
06:40AM  
06:09AM  
Mar-30-21 04:00PM  
Mar-28-21 07:00AM  
Mar-27-21 06:57AM  
Mar-25-21 08:05AM  
Mar-22-21 09:15AM  
Mar-19-21 07:49PM  
02:29PM  
Mar-18-21 03:42AM  
Mar-17-21 08:57AM  
Mar-16-21 01:57PM  
Mar-14-21 03:36AM  
Mar-13-21 08:32AM  
Mar-12-21 07:36PM  
Mar-11-21 04:00PM  
Mar-10-21 03:14PM  
Mar-05-21 07:03PM  
10:56AM  
10:05AM  
04:10AM  
Mar-04-21 06:27PM  
04:19PM  
03:34PM  
01:06PM  
01:00PM  
12:02PM  
11:45AM  
11:35AM  
11:30AM  
08:30AM  
06:54AM  
Mar-03-21 04:00PM  
09:01AM  
Mar-02-21 04:00PM  
Feb-26-21 12:35PM  
09:08AM  
09:00AM  
09:00AM  
Feb-24-21 04:00PM  
09:31AM  
Feb-23-21 10:59AM  
Feb-22-21 04:00PM  
09:12AM  
09:00AM  
Feb-17-21 07:26AM  
Feb-16-21 04:00PM  
Feb-12-21 07:30AM  
Feb-10-21 04:15PM  
10:33AM  
Feb-09-21 08:24PM  
04:00PM  
Feb-06-21 01:09AM  
Feb-05-21 03:16PM  
01:03PM  
Feb-03-21 04:00PM  
01:46PM  
12:03PM  
10:26AM  
10:25AM  
08:48AM  
08:47AM  
07:31AM  
06:44AM  
06:04AM  
Feb-02-21 11:30PM  
06:00PM  
05:55PM  
05:08PM  
04:42PM  
04:27PM  
04:15PM  
04:01PM  
02:45PM  
12:44PM  
06:59AM  
Feb-01-21 10:38AM  
10:03AM  
04:02AM  
Jan-29-21 04:00PM  
Jan-28-21 04:55PM  
04:00PM  
02:35PM  
10:20AM  
Jan-27-21 12:12PM  
Jan-26-21 04:00PM  
12:31PM  
09:40AM  
Jan-25-21 03:45PM  
Jan-23-21 09:38AM  
09:14AM  
Jan-21-21 10:29AM  
Jan-20-21 12:10PM  
Jan-19-21 10:20AM  
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behcet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; and Eli Lilly and Company. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUGAR RONALD DDirectorApr 14Option Exercise71.641,00071,64016,927Apr 15 06:27 PM
SUGAR RONALD DDirectorApr 14Sale249.981,000249,98015,927Apr 15 06:27 PM
SUGAR RONALD DDirectorMar 10Option Exercise71.641,00071,64016,805Mar 10 06:07 PM
SUGAR RONALD DDirectorMar 10Sale231.531,000231,53015,805Mar 10 06:07 PM
Bradway Robert AChairman, CEO and PresidentFeb 18Option Exercise54.6973,5004,019,715618,380Feb 22 07:27 PM
REESE DAVID MEVP, Research and DevelopmentFeb 16Option Exercise54.692,300125,78742,059Feb 16 08:59 PM
SUGAR RONALD DDirectorFeb 10Option Exercise71.641,00071,64016,805Feb 10 07:40 PM
SUGAR RONALD DDirectorFeb 10Sale238.401,000238,40015,805Feb 10 07:40 PM
Williams R SandersDirectorFeb 08Sale237.9925059,4984,659Feb 08 08:36 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Feb 04Sale236.5111,1102,627,62539,945Feb 05 08:06 PM
SUGAR RONALD DDirectorJan 13Option Exercise71.641,00071,64016,805Jan 14 06:25 PM
SUGAR RONALD DDirectorJan 13Sale235.991,000235,99015,805Jan 14 06:25 PM
Williams R SandersDirectorNov 09Sale242.4025060,6004,909Nov 10 06:32 PM
SUGAR RONALD DDirectorAug 19Option Exercise54.691,00054,69016,589Aug 19 06:00 PM
SUGAR RONALD DDirectorAug 19Sale241.021,000241,02015,589Aug 19 06:00 PM
Williams R SandersDirectorAug 07Sale242.9525060,7385,159Aug 10 05:42 PM
SUGAR RONALD DDirectorJul 22Option Exercise54.691,00054,69016,589Jul 22 06:11 PM
SUGAR RONALD DDirectorJul 22Sale259.791,000259,79015,589Jul 22 06:11 PM
SUGAR RONALD DDirectorJun 17Option Exercise54.691,00054,69016,576Jun 17 06:11 PM
SUGAR RONALD DDirectorJun 17Sale228.541,000228,54015,576Jun 17 06:11 PM
SUGAR RONALD DDirectorMay 20Option Exercise54.691,00054,69016,482May 20 09:24 PM
SUGAR RONALD DDirectorMay 20Sale229.271,000229,27015,482May 20 09:24 PM
Williams R SandersDirectorMay 06Sale237.31425100,8575,409May 07 08:49 PM
SUGAR RONALD DDirectorApr 22Option Exercise54.691,00054,69015,636Apr 22 07:07 PM
SUGAR RONALD DDirectorApr 22Sale233.351,000233,35014,636Apr 22 07:07 PM